{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "3082223",
  "DateCompleted": {
    "Year": "1986",
    "Month": "04",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2015",
    "Month": "11",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0002-953X",
      "JournalIssue": {
        "Volume": "143",
        "Issue": "4",
        "PubDate": {
          "Year": "1986",
          "Month": "Apr"
        }
      },
      "Title": "The American journal of psychiatry",
      "ISOAbbreviation": "Am J Psychiatry"
    },
    "ArticleTitle": "Depression in women treated for gynecological cancer: clinical and neuroendocrine assessment.",
    "Pagination": {
      "StartPage": "447",
      "EndPage": "452",
      "MedlinePgn": "447-52"
    },
    "Abstract": {
      "AbstractText": [
        "To determine the prevalence of major depression in cancer patients and assess the usefulness of the dexamethasone suppression test (DST) and the thyrotropin-releasing hormone (TRH) stimulation test for diagnosing major depression in these patients, the authors studied 83 women hospitalized for gynecological cancer. Nineteen (23%) had major depression according to DSM-III criteria. The sensitivity and specificity of the DST were 40% and 88%, respectively. No relationship between DST and TRH test results was found. These findings indicate a high prevalence of depression in cancer patients, but further research on these tests in cancer patients is needed; their routine use with cancer patients is premature at this time."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Evans",
        "ForeName": "D L",
        "Initials": "DL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "McCartney",
        "ForeName": "C F",
        "Initials": "CF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nemeroff",
        "ForeName": "C B",
        "Initials": "CB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Raft",
        "ForeName": "D",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Quade",
        "ForeName": "D",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Golden",
        "ForeName": "R N",
        "Initials": "RN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Haggerty",
        "ForeName": "J J",
        "Initials": "JJ",
        "Suffix": "Jr"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Holmes",
        "ForeName": "V",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Simon",
        "ForeName": "J S",
        "Initials": "JS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Droba",
        "ForeName": "M",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MH-33127",
        "Acronym": "MH",
        "Agency": "NIMH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R25 17973",
        "Agency": "PHS HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am J Psychiatry",
    "NlmUniqueID": "0370512",
    "ISSNLinking": "0002-953X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "5Y5F15120W",
      "NameOfSubstance": "Thyrotropin-Releasing Hormone"
    },
    {
      "RegistryNumber": "7S5I7G3JQL",
      "NameOfSubstance": "Dexamethasone"
    },
    {
      "RegistryNumber": "9002-71-5",
      "NameOfSubstance": "Thyrotropin"
    },
    {
      "RegistryNumber": "WI4X0X7BPJ",
      "NameOfSubstance": "Hydrocortisone"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "blood",
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "blood",
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dexamethasone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "complications",
        "psychology"
      ],
      "DescriptorName": "Genital Neoplasms, Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hospitalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Hydrocortisone"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychiatric Status Rating Scales"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Thyrotropin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Thyrotropin-Releasing Hormone"
    }
  ]
}